Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (Jul 31, 2012)
-
PR Newswire (Jul 24, 2012)
-
-
-
Review Of Analyst Upgrades This Week - Part VIThe Value Investor • Mon, May 28, 2012 -
PR Newswire (May 8, 2012)
-
-
PR Newswire (May 3, 2012)
-
-
-
Hologic Must Make The Third Time A CharmStephen Simpson • Tue, May 1, 2012
-
Gen-Probe's CEO Discusses Q1 2012 Results - Earnings Call TranscriptMon, Apr 30, 2012
-
PR Newswire (Apr 30, 2012)
-
PR Newswire (Apr 26, 2012)
-
-
-
PR Newswire (Apr 13, 2012)
-
PR Newswire (Mar 12, 2012)
-
Gen-Probe Looking To New Launches To Drive MomentumStephen Simpson • Tue, Feb 14, 2012
To learn more about Seeking Alpha Pro, click here.
-
Gen-Probe Looking To New Launches To Drive MomentumStephen Simpson • Tue, Feb 14, 2012
-
-
-
FDA Approves Gen-Probe AssayZacks Investment Research • Thu, Nov 26, 2009
-
-
-
-
Review Of Analyst Upgrades This Week - Part VIThe Value Investor • Mon, May 28, 2012
-
-
-
-
Hologic Must Make The Third Time A CharmStephen Simpson • Tue, May 1, 2012
-
-
-
-
Becton Dickinson Too Beloved For NowStephen Simpson • Tue, Feb 7, 2012
-
Skepticism Still Working For Hologic InvestorsStephen Simpson • Tue, Jan 31, 2012
-
-
7 Best Healthcare Stocks For 2012 According To BarclaysInsider Monkey • Mon, Dec 19, 2011 -
9 Of Richard F. Aster's Q2 Stock HoldingsDividend Screen • Tue, Sep 6, 2011 -
-
-
Monday Options RecapFrederic Ruffy • Mon, Jun 6, 2011 -
Thursday Options RecapFrederic Ruffy • Thu, May 19, 2011
-
Gen-Probe's CEO Discusses Q1 2012 Results - Earnings Call TranscriptMon, Apr 30, 2012
-
Gen-Probe's CEO Discusses Q4 2011 Results - Earnings Call TranscriptMon, Feb 13, 2012
-
Gen-Probe's CEO Discusses Q3 2011 Results - Earnings Call TranscriptWed, Nov 2, 2011
-
Gen-Probe's CEO Discusses Q2 2011 Results - Earnings Call TranscriptThu, Jul 28, 2011
-
Gen-probe Q3 2009 Earnings Call TranscriptFri, Oct 30, 2009
-
Gen Probe, Inc., Q4 2008 Earnings Call TranscriptTue, Feb 17, 2009
-
Gen-Probe Inc. Q3 2008 Earnings Conference Call TranscriptFri, Oct 31, 2008
-
Gen-Probe, Inc. Q2 2008 Earnings CallThu, Jul 31, 2008
-
Gen Probe Incorporated Q1 2008 Earnings Call TranscriptTue, Apr 29, 2008
-
Gen-Probe, Inc. Q4 2007 Earnings Call TranscriptWed, Feb 13, 2008
-
Gen-Probe Inc. Q3 2007 Earnings Call TranscriptTue, Oct 30, 2007
-
Gen-Probe Q2 2007 Earnings Call TranscriptWed, Aug 1, 2007
-
Gen-Probe Q1 2007 Earnings Call TranscriptTue, May 1, 2007
-
Gen-Probe Q4 2006 Earnings Call TranscriptTue, Feb 13, 2007
-
Gen-Probe Q3 2006 Earnings Call TranscriptWed, Nov 1, 2006
-
Gen-Probe Q4 2005 Earnings Conference Call Transcript (GPRO)Mon, Feb 20, 2006
-
PR Newswire (Jul 31, 2012)
-
at MarketWatch.com (Jul 26, 2012)
-
PR Newswire (Jul 24, 2012)
-
PR Newswire (May 8, 2012)
-
PR Newswire (May 3, 2012)
-
at CNBC.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 30, 2012)
-
at MarketWatch.com (Apr 30, 2012)
-
PR Newswire (Apr 30, 2012)
-
PR Newswire (Apr 26, 2012)
-
PR Newswire (Apr 13, 2012)
-
PR Newswire (Mar 12, 2012)
-
at MarketWatch.com (Feb 8, 2012)
-
PR Newswire (Jan 27, 2012)
-
PR Newswire (Jan 9, 2012)
-
PR Newswire (Jan 4, 2012)
-
PR Newswire (Dec 9, 2011)
-
at MarketWatch.com (Sep 29, 2011)
-
at CNBC.com (Jun 7, 2011)
-
at MarketWatch.com (Jun 6, 2011)
GPRO vs. ETF Alternatives
Company Description
Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests, or NATs, used primarily to diagnose human diseases and screen donated human blood. NATs are designed to detect diseases more rapidly... More
